Literature DB >> 33704815

Multiple Sclerosis Is Rare in Epstein-Barr Virus-Seronegative Children with Central Nervous System Inflammatory Demyelination.

Bardia Nourbakhsh1, Christian Cordano2, Carlo Asteggiano2,3, Klemens Ruprecht4, Carolin Otto4, Alice Rutatangwa2, Allysa Lui2, Janace Hart2, Eoin P Flanagan5, Judith A James6, Emmanuelle Waubant2.   

Abstract

Although Epstein-Barr virus (EBV) is hypothesized to be a prerequisite for multiple sclerosis (MS), up to 15% of children with a diagnosis of MS were reported to be EBV-seronegative. When re-evaluating 25 EBV-seronegative children out of 189 pediatric patients with a diagnosis of clinically isolated syndrome/MS, we found anti-myelin oligodendrocyte glycoprotein (MOG) antibody in 11 of 25 (44%) EBV-seronegative but only 9 of 164 (5.5%, p < 0.001) EBV-seropositive patients. After critical review, MS remained a plausible diagnosis in only 4 of 14 EBV-seronegative/MOG antibody-negative patients. In children with an MS-like presentation, EBV seronegativity should alert clinicians to consider diagnoses other than MS, especially MOG-antibody disease. ANN NEUROL 2021;89:1234-1239.
© 2021 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33704815      PMCID: PMC8244760          DOI: 10.1002/ana.26062

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   11.274


  14 in total

Review 1.  Environmental risk factors for multiple sclerosis. Part I: the role of infection.

Authors:  Alberto Ascherio; Kassandra L Munger
Journal:  Ann Neurol       Date:  2007-04       Impact factor: 10.422

2.  Common viruses associated with lower pediatric multiple sclerosis risk.

Authors:  E Waubant; E M Mowry; L Krupp; T Chitnis; E A Yeh; N Kuntz; J Ness; D Chabas; J Strober; J McDonald; A Belman; M Milazzo; M Gorman; B Weinstock-Guttman; M Rodriguez; J R Oksenberg; J A James
Journal:  Neurology       Date:  2011-06-07       Impact factor: 9.910

3.  Primary infection with the Epstein-Barr virus and risk of multiple sclerosis.

Authors:  Lynn I Levin; Kassandra L Munger; Eilis J O'Reilly; Kerstin I Falk; Alberto Ascherio
Journal:  Ann Neurol       Date:  2010-06       Impact factor: 10.422

4.  The role of Epstein-Barr virus in the etiology of multiple sclerosis: a current review.

Authors:  Klemens Ruprecht
Journal:  Expert Rev Clin Immunol       Date:  2020-12-17       Impact factor: 4.473

5.  Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study.

Authors:  Brenda Banwell; Lauren Krupp; Julia Kennedy; Raymond Tellier; Silvia Tenembaum; Jayne Ness; Anita Belman; Alexei Boiko; Olga Bykova; Emmanuelle Waubant; Jean K Mah; Cristina Stoian; Marcelo Kremenchutzky; Maria Rita Bardini; Martino Ruggieri; Mary Rensel; Jin Hahn; Bianca Weinstock-Guttman; E Ann Yeh; Kevin Farrell; Mark Freedman; Matti Iivanainen; Meri Sevon; Virender Bhan; Marie-Emmanuelle Dilenge; Derek Stephens; Amit Bar-Or
Journal:  Lancet Neurol       Date:  2007-09       Impact factor: 44.182

6.  International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions.

Authors:  Lauren B Krupp; Marc Tardieu; Maria Pia Amato; Brenda Banwell; Tanuja Chitnis; Russell C Dale; Angelo Ghezzi; Rogier Hintzen; Andrew Kornberg; Daniela Pohl; Kevin Rostasy; Silvia Tenembaum; Evangeline Wassmer
Journal:  Mult Scler       Date:  2013-04-09       Impact factor: 6.312

7.  A multicenter comparison of MOG-IgG cell-based assays.

Authors:  Patrick J Waters; Lars Komorowski; Mark Woodhall; Sabine Lederer; Masoud Majed; Jim Fryer; John Mills; Eoin P Flanagan; Sarosh R Irani; Amy C Kunchok; Andrew McKeon; Sean J Pittock
Journal:  Neurology       Date:  2019-02-06       Impact factor: 9.910

Review 8.  MOG encephalomyelitis: international recommendations on diagnosis and antibody testing.

Authors:  S Jarius; F Paul; O Aktas; N Asgari; R C Dale; J de Seze; D Franciotta; K Fujihara; A Jacob; H J Kim; I Kleiter; T Kümpfel; M Levy; J Palace; K Ruprecht; A Saiz; C Trebst; B G Weinshenker; B Wildemann
Journal:  J Neuroinflammation       Date:  2018-05-03       Impact factor: 8.322

9.  Serial Anti-Myelin Oligodendrocyte Glycoprotein Antibody Analyses and Outcomes in Children With Demyelinating Syndromes.

Authors:  Patrick Waters; Giulia Fadda; Mark Woodhall; Julia O'Mahony; Robert A Brown; Denise A Castro; Giulia Longoni; Sarosh R Irani; Bo Sun; E Ann Yeh; Ruth Ann Marrie; Douglas L Arnold; Brenda Banwell; Amit Bar-Or
Journal:  JAMA Neurol       Date:  2020-01-01       Impact factor: 18.302

10.  Systematic review and meta-analysis of the association between Epstein-Barr virus, multiple sclerosis and other risk factors.

Authors:  Benjamin M Jacobs; Gavin Giovannoni; Jack Cuzick; Ruth Dobson
Journal:  Mult Scler       Date:  2020-03-23       Impact factor: 6.312

View more
  2 in total

Review 1.  Preventing Multiple Sclerosis: The Pediatric Perspective.

Authors:  Duriel Hardy; Tanuja Chitnis; Emmanuelle Waubant; Brenda Banwell
Journal:  Front Neurol       Date:  2022-02-25       Impact factor: 4.003

2.  Serum MOG-IgG in children meeting multiple sclerosis diagnostic criteria.

Authors:  Giulia Fadda; Patrick Waters; Mark Woodhall; Robert A Brown; Julia O'Mahony; Denise A Castro; Giulia Longoni; E Ann Yeh; Ruth Ann Marrie; Douglas L Arnold; Brenda Banwell; Amit Bar-Or
Journal:  Mult Scler       Date:  2022-05-17       Impact factor: 5.855

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.